Grants per year
Personal profile
Research Interests
Abnormal uterine bleeding, Adolescent health, Annual gynecological examinations, Menopause and menopausal symptoms, Minimally invasive treatment options, Osteoporosis and bone health, Uterine fibroids
Training Experience
| 2000 | Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
Medicine, MD, Northwestern University Feinberg School of Medicine
… → 1996
Fingerprint
Dive into the research topics where Michelle Mourot Luthringshausen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Grants
- 12 Finished
-
Prot# 511.133: A Twenty-eight Week, Open-label, Safety, Extension Trial of Flibanserin 100 Milligrams Daily in Premenopausal and Naturally Postmenopausal Women with Hypoactive Sexual Desire in North America
Stika, C. S., Dungan, J. S., Luthringshausen, M. M., Shulman, L. P. & Tsai, S.
Boehringer Ingelheim Pharmaceuticals, Inc.
7/30/10 → 7/30/13
Project: Research project
-
Prot# 511.156: A Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled, Safety And Efficacy Trial of Flibanserin, With Up-Titration, 100 Milligrams Administered Orally Once Daily in Naturally Postmenopausal Women With Hypoactive Sexual Desire Dis
Stika, C. S., Dungan, J. S., Luthringshausen, M. M. & Shulman, L. P.
Boehringer Ingelheim Pharmaceuticals, Inc.
5/20/10 → 5/20/13
Project: Research project
-
Prot# TESTW008: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Libigel For the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Stika, C. S., Luthringshausen, M. M., Shulman, L. P. & Streicher, L. F.
BioSante Pharmaceuticals, Inc.
8/25/08 → 8/5/12
Project: Research project
-
Prot# TESTW007: A Phase III, Randomized, Double-B
Stika, C. S., Luthringshausen, M. M. & Shulman, L. P.
BioSante Pharmaceuticals, Inc.
8/25/08 → 8/25/11
Project: Research project